<DOC>
	<DOCNO>NCT00536497</DOCNO>
	<brief_summary>GW842166X selective non-cannabinoid CB2 receptor agonist , undergo clinical development novel oral treatment inflammatory pain . The purpose study compare effect formulation , food particle size pharmacokinetic profile single 175mg dose GW842166X healthy male female volunteer .</brief_summary>
	<brief_title>Relative Bioavailability Study Single Dose GW842166X Healthy Male Female Subjects .</brief_title>
	<detailed_description />
	<criteria>Body weight &gt; 50 Kg BMI within range 18.529.9 Kg/m2 inclusive . Healthy judge responsible physician . Positive prestudy urine screen drug abuse alcohol breath test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>GW842166 ,</keyword>
	<keyword>Healthy volunteer ,</keyword>
	<keyword>Inflammatory Pain .</keyword>
</DOC>